Fluoresentric Raises Series B

Salt Lake City-based Fluoresentric, a startup developing Polymerase Chain Reaction (PCR) technology, said Monday that it has raised a Series B funding round. Size of the funding round, and name of its investors, were not announced. The startup, which is led by William Olsen, said it is using the funding to transition from a developer of polymerase chain reaction (PCR) assay design to licensing of its technology for genetic testing. More information »